Archives

  • Special Supplement, Fall 2025

    • Addressing Metabolic Dysfunction‑Associated Steatotic Liver Disease (MASLD) in Endocrinology Settings in Canada: From Prevalence to Patient-Centered Management

  • Volume 3, Issue 3, Fall 2025

    • Optimizing the Use of Automated Insulin Delivery (AID) Systems in Routine Clinical Care of People with Type 1 Diabetes
    • Ilana Halperin, MD, MSc, FRCPC Youth-Onset Type 2 Diabetes: A Review
    • Running a Trans-Welcoming Clinical Practice
    • Novel Treatment Options For Menopausal Symptoms

  • Volume 3, Issue 2, Summer 2025

    • Autoantibodies in Type 1 Diabetes
    • Current and Emerging Treatments For the Management of Hypoparathyroidism
    • Vaccinating Your Adult Diabetic Patient: What Vaccines Would You Recommend?
    • Thyroid Nodules: Reducing Overdiagnosis and Investigations

  • Volume 3, Issue 1, Spring 2025

    • Addressing Inositol Use in PCOS Management
    • Diabetes Remission: Where are We Now? 
    • Glucagon-like Peptide-1 Receptor Agonists and Thyroid Cancer:  Myth or Reality? 
    • The Role of GLP-1R and GIPR Agonism in Heart Failure
    • GLP-1 Receptor Agonist Use in Pregnancy

  • Volume 2, Issue 3, Fall 2024

    • Cardiovascular Safety of Testosterone Replacement Therapy in Hypogonadal Men
    • The Role of Bisphosphonate Drug Holidays in the Management of Osteoporosis
    • Treatment of Obesity in Individuals with Type 1 Diabetes
    • Glucagon-like Peptide Receptor Agonists (GLP-1 receptor agonists): A Powerful Addition to Foundational Therapy Kidney Care in Patients with Type 2 Diabetes Mellitus
    • Monogenic and Syndromic Obesity: Therapeutic Implications

  • Volume 2, Issue 2, Summer 2024

    • Aging In The Face of Diabetes: Severe Hypoglycemia in Older Adults
    • Obstructive Sleep Apnea and Type 2 Diabetes
    • A Practical Approach to the Incidental Adrenal Mass
    • Finerenone in Diabetic Kidney Disease

  • Volume 2, Issue 1, Spring 2024

    • Risk Stratification to Improve Care and Outcomes in Diabetic Kidney Disease
    • Role of Continuous Glucose Monitoring in Non-Insulin-Requiring Type 2 Diabetes
    • From the Bottom Up: Foot Care in Diabetes and the Role of the Endocrinologist
    • Diabetes Management at Time of Childbirth
    • Diabetes and Osteoporosis

  • Volume 1, numéro 3, octobre 2023

    • Lipoprotein (a) in Cardiovascular Risk Assessment and Management in Diabetes Mellitus
    • Approach to the Management of Thyroid Eye Disease
    • The Role of Plant-Based Diets in the Management of Type 2 Diabetes
    • Glucagon-like Peptide-1 Receptor Agonist Treatment in Type 1 Diabetes: A Review of Current Evidence and Rationale for Use
    • Case Report: A First Nation Man’s Journey with Severe Insulin Resistance Syndrome

  • Volume 1, numéro 2, juin 2023

    • Endocrinopathies associées aux inhibiteurs de points de contrôle immunitaires
    • Rôle futur des agents antihyperglycémiques non-insuliniques dans la prise en charge du diabète de type 1
    • Prise en charge du diabète pédiatrique de type 2 : Aperçu pratique des lignes directrices actuelles et des thérapies émergentes
    • Exercice de résistance dans le contexte du diabète de type 1
    • Amélioration de l’accès aux endocrinologues grâce aux consultations électroniques entre professionnels de la santé

  • Volume 1, numéro 1, mars 2023

    • Comment appliquer les lignes directrices canadiennes de pratique clinique sur l’obésité aux personnes atteintes de diabète de type 2
    • Prise en considération des cannabinoïdes dans le traitement de la douleur neuropathique périphérique diabétique
    • Rémission du diabète de type 2 : Une vue d'ensemble
    • L’utilisation des insulines biosimilaires en 2023
    • Traitement de la NAFLD comme une complication du diabète de type 2 à l’aide de techniques évolutives de diagnostic et de prise en charge